ATIM-25. TEN-YEAR FOLLOW UP WITH LONG TERM REMISSION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) TREATED WITH ICT-107 VACCINE (PHASE I)

Authors :: Miriam A Nuno
Christopher J. Wheeler
Jeremy Rudnick
Keith L. Black
Ray M Chu
Jethro Hu
Surasak Phuphanich
John S. Yu
Mia Mazer
Cherry Sanchez
Source :: Neuro-Oncology. 18:vi23-vi23
Publication Year :: 2016
Publisher :: Oxford University Press (OUP), 2016.

Subjects :: 0301 basic medicine
Cancer Research
Pediatrics
medicine.medical_specialty
business.industry
Newly diagnosed
medicine.disease
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Oncology
030220 oncology & carcinogenesis
medicine
In patient
Neurology (clinical)
Long term remission
business
Glioblastoma

Full Text Access

Tools